Please use this identifier to cite or link to this item: https://doi.org/10.3390/ijerph110404158
DC FieldValue
dc.titleManaging terrorism or accidental nuclear errors, preparing for iodine-131 emergencies: A comprehensive review
dc.contributor.authorBraverman, E.R
dc.contributor.authorBlum, K
dc.contributor.authorLoeffke, B
dc.contributor.authorBaker, R
dc.contributor.authorKreuk, F
dc.contributor.authorYang, S.P
dc.contributor.authorHurley, J.R
dc.date.accessioned2020-11-18T07:36:48Z
dc.date.available2020-11-18T07:36:48Z
dc.date.issued2014
dc.identifier.citationBraverman, E.R, Blum, K, Loeffke, B, Baker, R, Kreuk, F, Yang, S.P, Hurley, J.R (2014). Managing terrorism or accidental nuclear errors, preparing for iodine-131 emergencies: A comprehensive review. International Journal of Environmental Research and Public Health 11 (4) : 4158-4200. ScholarBank@NUS Repository. https://doi.org/10.3390/ijerph110404158
dc.identifier.issn16617827
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/183662
dc.description.abstractChernobyl demonstrated that iodine-131 (131I) released in a nuclear accident can cause malignant thyroid nodules to develop in children within a 300 mile radius of the incident. Timely potassium iodide (KI) administration can prevent the development of thyroid cancer and the American Thyroid Association (ATA) and a number of United States governmental agencies recommend KI prophylaxis. Current pre-distribution of KI by the United States government and other governments with nuclear reactors is probably ineffective. Thus we undertook a thorough scientific review, regarding emergency response to 131I exposures. We propose: (1) pre-distribution of KI to at risk populations; (2) prompt administration, within 2 hours of the incident; (3) utilization of a lowest effective KI dose; (4) distribution extension to at least 300 miles from the epicenter of a potential nuclear incident; (5) education of the public about dietary iodide sources; (6) continued post-hoc analysis of the long-term impact of nuclear accidents; and (7) support for global iodine sufficiency programs. Approximately two billion people are at risk for iodine deficiency disorder (IDD), the world's leading cause of preventable brain damage. Iodide deficient individuals are at greater risk of developing thyroid cancer after 131I exposure. There are virtually no studies of KI prophylaxis in infants, children and adolescents, our target population. Because of their sensitivity to these side effects, we have suggested that we should extrapolate from the lowest effective adult dose, 15-30 mg or 1-2 mg per 10 pounds for children. We encourage global health agencies (private and governmental) to consider these critical recommendations. © 2014 by the authors; licensee MDPI, Basel, Switzerland.
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceUnpaywall 20201031
dc.subjectiodide
dc.subjectiodine
dc.subjectiodine 131
dc.subjectpotassium iodide
dc.subjectsodium iodide
dc.subjectthyroid hormone
dc.subjecterror analysis
dc.subjecthealth care
dc.subjecthealth education
dc.subjecthealth risk
dc.subjecthealth services
dc.subjectiodine
dc.subjectnuclear accident
dc.subjectpotassium
dc.subjectabdominal discomfort
dc.subjectallergic reaction
dc.subjectanemia
dc.subjectbone marrow suppression
dc.subjectChernobyl accident
dc.subjectchromosome aberration
dc.subjectcomorbidity
dc.subjectdietary reference intake
dc.subjectdose response
dc.subjectdrug formulation
dc.subjectdrug megadose
dc.subjectdrug stability
dc.subjectemergency health service
dc.subjectepiphora
dc.subjectfatigue
dc.subjectfood intake
dc.subjectgastrointestinal symptom
dc.subjectgovernment regulation
dc.subjecthealth care availability
dc.subjecthealth education
dc.subjecthealth program
dc.subjecthuman
dc.subjecthyperthyroidism
dc.subjecthypothyroidism
dc.subjectinfertility
dc.subjectiodine deficiency
dc.subjectleukemia
dc.subjectleukopenia
dc.subjectlung fibrosis
dc.subjectmental disease
dc.subjectmetastasis
dc.subjectmeteorology
dc.subjectnausea
dc.subjectnuclear accident
dc.subjectphobia
dc.subjectplume
dc.subjectradiation detection
dc.subjectradiation exposure
dc.subjectradiation sickness
dc.subjectradioactivity
dc.subjectradiobiology
dc.subjectrash
dc.subjectrecommended drug dose
dc.subjectreview
dc.subjectrisk factor
dc.subjectshelf life
dc.subjectsialoadenitis
dc.subjectsingle drug dose
dc.subjecttaste disorder
dc.subjectterrorism
dc.subjectthrombocytopenia
dc.subjectthyroid cancer
dc.subjectthyroid carcinoma
dc.subjectthyroid disease
dc.subjectthyroiditis
dc.subjecttoxic goiter
dc.subjectunspecified side effect
dc.subjectvomiting
dc.subjectxerostomia
dc.subjectUnited States
dc.subjectHumans
dc.subjectIodine Radioisotopes
dc.subjectPotassium Iodide
dc.subjectRadiation Injuries
dc.subjectRadioactive Hazard Release
dc.subjectTerrorism
dc.typeReview
dc.contributor.departmentMEDICINE
dc.description.doi10.3390/ijerph110404158
dc.description.sourcetitleInternational Journal of Environmental Research and Public Health
dc.description.volume11
dc.description.issue4
dc.description.page4158-4200
Appears in Collections:Staff Publications
Elements

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_3390_ijerph110404158.pdf1.35 MBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons